Transforming Pharma Consulting: The Fractional Model with Mary Hames

In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.00:00 Introduction to BioLogic Pharma Solutions03:01 The Fractional Model in Biotech Consulting06:00 Navigating Uncertainty in Drug Development09:04 Mary's Entrepreneurial Journey11:50 Vision for the Future of Biotech Consulting14:45 Challenges in Consulting and Growth17:57 The Importance of Trust in Entrepreneurship26:49 The Importance of Delegation in Business28:02 Navigating Client Acquisition and Marketing Strategies30:35 Effective Client Engagement and Presentation Techniques34:12 Understanding Market Dynamics and Client Feedback36:11 Identifying the Sweet Spot in the Drug Development Process39:25 Building a Flexible Workforce and Consultant Relationships40:19 Future Aspirations and Growth Strategies for the Company46:12 Reflections on the Entrepreneurial JourneyGuest Information:Guest's Name: Mary Hames Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/Company / Affiliation: BioLogic Pharma Solutions https://biologicpharmasolutions.com/Guest's Bio: Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency. Takeaways:The fractional model allows companies to access expertise without full-time hires.Building a company culture is essential for employee satisfaction.Consulting can be lonely, but teamwork helps mitigate that.Marketing strategies include presentations and SEO efforts.Trust is crucial for entrepreneurs to delegate responsibilities.The future of BioLogic includes becoming a go-to firm for pre-commercial products.Navigating uncertainty in drug development is a common challenge.Mary's entrepreneurial journey includes learning from past failures.The sweet spot for consulting is between phase two and three of drug development.